Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart Failure
An Exploratory, Randomized, Double-blind, Placebo-controlled, Parallel Arm Trial of the Safety and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients Hospitalized With Worsening Heart Failure
Sponsor: Lexicon Pharmaceuticals
Terminated
1st two cohorts provided the required data, therefore 3rd cohort was not deemed necessary
Other terminated trials from Lexicon Pharmaceuticals
This PHASE2 trial investigates Cardiac Failure Aggravated and is currently terminated or withdrawn. Lexicon Pharmaceuticals leads this study, which shows 25 recorded versions since 2017 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
25 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jun 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jun 2021 [monthly]
Terminated PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 20 earlier versions
-
Jun 2020 — Sep 2020 [monthly]
Terminated PHASE2
Status: Suspended → Terminated
-
Mar 2020 — Jun 2020 [monthly]
Suspended PHASE2
-
Jan 2020 — Mar 2020 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Nov 2019 — Jan 2020 [monthly]
Recruiting PHASE2
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE2
-
Jul 2019 — Oct 2019 [monthly]
Recruiting PHASE2
-
Apr 2019 — Jul 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Apr 2019 [monthly]
Recruiting PHASE2
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE2
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE2
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Apr 2018 — May 2018 [monthly]
Recruiting PHASE2
-
Mar 2018 — Apr 2018 [monthly]
Recruiting PHASE2
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE2
-
Dec 2017 — Feb 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Dec 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Lexicon Pharmaceuticals
- Sanofi
For direct contact, visit the study record on ClinicalTrials.gov .